First author, Year | Country | Study design | Patients (n) | Age (Year) | Gender (male/female) | Haemodynamic | Follow-Up | NOS (*) |
---|---|---|---|---|---|---|---|---|
Lankeit M, 2011 | Germany, Spain, Poland, Greece | Prospective | 526 | 71 (55–79) | 266/260 | Stable | 6 month | 8 |
Sánchez D, 2011 | Spain, Switzerland, USA | Retrospective | 1291 | 74 (61–80) | 579/712 | Stable and unstable | 30 day | 7 |
Lankeit M,2012 | Germany, Spain, Greece | Prospective | 526 | 74 (61–80) | 227/299 | Stable and unstable | 30 day | 7 |
Righini M,2011 | Switzerland, France, Belgium | Prospective | 357 | mean age 64 | 157/200 | Stable and unstable | 3 month | 8 |
Spirk D, 2011 | Switzerland | Prospective | 369 | 20.9% >80 | 195/174 | Stable and unstable | 30 day | 8 |
Vanni S, 2011 | Italy | Prospective | 463 | 67% > 65 | 208/254 | Stable and unstable | in-hospital stay | 8 |
Venetz C, 2011 | Switzerland, Spain | Not mentioned | 15531 | 67 (52–77) | 6227/9304 | Stable and unstable | 30 day | 7 |
Hariharan P, 2011 | USA | Retrospective | 245 | 57 ± 17 | 115/130 | Stable and unstable | in-hospital stay | 8 |
Jiménez D, 2011 | Spain, Switzerland, USA, Greece | Not mentioned | 591 | 74 (65–82) | 254/337 | Stable | 30 day | 7 |
Singanayagam A,2011 | UK | Retrospective | 411 | 55.4% >65 | 177/234 | Stable and unstable | 30 day | 8 |
Jiménez D, 2010 (Derivation Cohort) | Spanish, France, Italy, Israel | Retrospective | 10354 | 52.8% >65 | 4100/6254 | Stable and unstable | 30 day | 7 |
Jiménez D, 2010 (Derivation Cohort) | Spanish, France, Italy, Israel | Retrospective | 995 | 67.4% >65 | 449/546 | Stable and unstable | 30 day | 7 |
Jiménez D, 2010 (RIETE Cohort) | Spanish, France, Italy, Israel | Retrospective | 7106 | 68.2% >65 | 3232/3874 | Stable and unstable | 30 day | 7 |
Sam A, 2011 | Spain, USA, Switzerland | Prospective | 1206 | 69.3±16.1 | 536/670 | Stable and unstable | 30 day | 8 |
Chan CM, 2010 | USA | Retrospective | 302 | 59.7±17.2 | 133/169 | Stable and unstable | 90 day | 8 |
Singanayagam A, 2010 | UK | Retrospective | 585 | 55.4% >65 | 258/327 | Stable and unstable | 30 day | 7 |
Moores L, 2010 | USA, Switzerland, Spain | Retrospective | 567 | 74% >65 | 245/322 | Stable | 30 day | 7 |
Nordenholz K, 2011 | USA | Retrospective | 168 | 53 (40–66) | 72/96 | Stable and unstable | 30 day | 7 |
Choi WH,2009 | Korea | Retrospective | 90 | 60.4±16.0 | 37/53 | Stable and unstable | 30 day | 7 |
Donzé J, 2008 | Switzerland, France, USA | Prospective | 357 | 64±18 | 158/199 | Stable | 90 day | 8 |
Jiménez D, 2008 | Spain, USA | Prospective | 318 | 75.5% >65 | 136/182 | Stable | 30 day | 8 |
Jiménez D, 2007 (Validation Cohort) | Spain | Prospective | 599 | 67% >65 | 246/353 | Stable and unstable | 30 day | 8 |
Aujesky D,2007 | Switzerland, France, USA | Prospective | 899 | 64% >65 | 382/517 | Stable and unstable | 30 day | 8 |